title: Does homocysteine-lowering treatment improve cardiovascular outcomes in patients with acute coronary syndromes? What we have learned from clinical trials?
authors: Turgay
authors: T
authors: Celik
authors: Atila
authors: A
authors: Iyisoy
authors: Baris
authors: B
authors: Bugan
authors: U Cagdas
authors: UC
authors: Yuksel
authors: Ersoy
authors: E
authors: Isik
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects; D006801:Humans; D020138:Hyperhomocysteinemia / Q000188:drug therapy*; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D006710:Homocysteine